Ann: Appendix 4C - quarterly, page-224

"Remember, we are recruiting people who have just been diagnosed with cancer... many of them young(ish) women. Their first thought is TREATMENT, not helping a novel imaging manufacturer with their trial. We can surely allow people to be panicked and selfish in this moment?"

Flash, you raised a good point here and i agree with you.

But on reflection i think IBX does have the potential to at least 'assist' the treatment due to its ability to accurately monitor the tumour during treatment.

If the technology proved safe and demonstrated efficacy during this first trial, and as a patient i was diagnosed and began treatment during 2021 say, i would like to think that i could get another dose during my treatment to assess the effectivness of the treatment. Otherwise i have to wait for approval which is still years away.

The monitoring capability would incentivise me to be part of the trial.

I wonder if the trial protocols allow for this or whether thats beyond the scope of this trial.